AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1725148 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotrimoxazole 160/800mg
Number of subjects: 123
Study 1725148 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study 6336952 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% acyclovir and 0.01% betamethasone drops
Number of subjects: 40
Study 6336952 — intervention group
Group type: COMPARATOR
Intervention: Acyclovir alone
Number of subjects: 40
Study 31776915 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodynamic monitoring with CardioMEMS PA sensor
Number of subjects: 340
Study 31776915 — intervention group
Group type: COMPARATOR
Intervention: Standard HF care alone
Number of subjects: 340
Study 30878487 — intervention group
Group type: EXPERIMENTAL
Intervention: rAAV.sFLT-1 gene therapy (GT)
Number of subjects: 37
Study 30878487 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 37
Study 27567022 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave treatment (rESWT) - two sessions, 2,000 shock waves per session, energy flux density of 0.16 mJ/mm2
Number of subjects: 50
Study 27567022 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 50
Study 27567022 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave treatment (rESWT)
Number of subjects: 50
Study 26639151 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaf concentrate powder (LCP) 10 g daily
Number of subjects: 83
Study 26639151 — intervention group
Group type: COMPARATOR
Intervention: Skimmed milk powder (SMP) 15 g daily
Number of subjects: 83
Study 26639151 — intervention group
Group type: EXPERIMENTAL
Intervention: Leaf concentrate powder (LCP)
Number of subjects: 83
Study 26639151 — intervention group
Group type: COMPARATOR
Intervention: Skimmed milk powder (SMP)
Number of subjects: 83
Study 25134956 — intervention group
Group type: EXPERIMENTAL
Intervention: Solid-head power toothbrush
Number of subjects: 0
Study 25134956 — intervention group
Group type: COMPARATOR
Intervention: Hollow-head power toothbrush 1
Number of subjects: 0
Study 25134956 — intervention group
Group type: COMPARATOR
Intervention: Hollow-head power toothbrush 2
Number of subjects: 0
Study 22641493 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-core biopsy
Number of subjects: 474
Study 22641493 — intervention group
Group type: COMPARATOR
Intervention: 10-core biopsy
Number of subjects: 474
Study 18952469 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help intervention
Number of subjects: 1000
Study 18952469 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face treatments
Number of subjects: 1000
Study 17501954 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA-PDT
Number of subjects: 16
Study 17501954 — intervention group
Group type: COMPARATOR
Intervention: MAL-PDT
Number of subjects: 16
Study 15327047 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP) 24 mg/day
Number of subjects: 60
Study 15327047 — intervention group
Group type: EXPERIMENTAL
Intervention: fluoxetine (FLX) 20 mg/day
Number of subjects: 60
Study 15327047 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo effect implied)
Number of subjects: 60
Study 11346221 — intervention group
Group type: EXPERIMENTAL
Intervention: Meloxicam 7.5 mg daily for 4 weeks
Number of subjects: 0
Study 11346221 — intervention group
Group type: COMPARATOR
Intervention: Piroxicam 20 mg daily for 4 weeks
Number of subjects: 0
Study 9222189 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type B (BTXB)
Number of subjects: 17
Study 9222189 — intervention group
Group type: COMPARATOR
Intervention: Botulinum toxin type A (BTXA)
Number of subjects: 17
Study 8431908 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 0
Study 8431908 — intervention group
Group type: COMPARATOR
Intervention: Misonidazole
Number of subjects: 0
Study 8431908 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin with infusional 5-fluorouracil
Number of subjects: 0
Study 8431908 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemotherapy with extended field radiation
Number of subjects: 0
Study 3631918 — intervention group
Group type: EXPERIMENTAL
Intervention: Scopolamine (0.25 mg)
Number of subjects: 64
Study 3631918 — intervention group
Group type: COMPARATOR
Intervention: Control (no scopolamine)
Number of subjects: 64
Study 30016516 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-biofortified pearl millet (Fe = 86 ppm)
Number of subjects: 140
Study 30016516 — intervention group
Group type: COMPARATOR
Intervention: Conventional pearl millet (Fe = 21-52 ppm)
Number of subjects: 140
Study 30016516 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-biofortified pearl millet
Number of subjects: 140
Study 30016516 — intervention group
Group type: COMPARATOR
Intervention: Conventional pearl millet
Number of subjects: 140
Study 26915374 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan 97/103 mg twice daily
Number of subjects: 8399
Study 26915374 — intervention group
Group type: COMPARATOR
Intervention: Enalapril 10 mg twice daily
Number of subjects: 8399
Study 25321314 — intervention group
Group type: EXPERIMENTAL
Intervention: KinFact intervention
Number of subjects: 490
Study 25321314 — intervention group
Group type: COMPARATOR
Intervention: Control handout
Number of subjects: 490
Study 22468766 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose + maltodextrin solution
Number of subjects: 26
Study 22468766 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose + maltodextrin solution (adjusted for gastrointestinal discomfort)
Number of subjects: 26
Study 20429674 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month physical activity counselling programme
Number of subjects: 347
Study 20429674 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 347
Study 18463957 — intervention group
Group type: EXPERIMENTAL
Intervention: D2 gastrectomy
Number of subjects: 269
Study 18463957 — intervention group
Group type: EXPERIMENTAL
Intervention: D4 gastrectomy
Number of subjects: 269
Study 18463957 — intervention group
Group type: COMPARATOR
Intervention: D2 vs D4 comparison
Number of subjects: 269
Study 16248240 — intervention group
Group type: COMPARATOR
Intervention: Diane-35 in the Western medicine group (WMG)
Number of subjects: 63
Study 16248240 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional controlled medicine plus modified Yougui Pill in the integrative medicine group (IMG)
Number of subjects: 63
Study 12573751 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmastectomy irradiation
Number of subjects: 0
Study 12573751 — intervention group
Group type: COMPARATOR
Intervention: Older trials not guided by well-developed guidelines
Number of subjects: 0
Study 15022968 — intervention group
Group type: EXPERIMENTAL
Intervention: Cochrane Library systematic reviews relevant to pain management and palliative care
Number of subjects: 10
Study 15022968 — intervention group
Group type: COMPARATOR
Intervention: Cochrane Library systematic reviews
Number of subjects: 10
Study 9607357 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy, 12 courses of cyclophosphamide, methotrexate, and 5‐fluorouracil (CMF), and tamoxifen (arm II)
Number of subjects: 118
Study 9607357 — intervention group
Group type: EXPERIMENTAL
Intervention: Adriamycine, vincristine (AV) alternated with CMF, then radiotherapy, followed by four cycles of chemotherapy (AV/CMF); and tamoxifen during the entire treatment period (arm III)
Number of subjects: 118
Study 9607357 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (arm I)
Number of subjects: 118
Study 7617803 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (20 micrograms/kg) administered 30 min before challenge
Number of subjects: 16
Study 7617803 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (20 micrograms/kg) administered 60 min before challenge
Number of subjects: 16
Study 7617803 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine (20 micrograms/kg) administered 120 min before challenge
Number of subjects: 16
Study 7617803 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered 30 min before challenge
Number of subjects: 16
Study 2197538 — intervention group
Group type: EXPERIMENTAL
Intervention: Azidothymidine plus aerosolized pentamidine
Number of subjects: 27
Study 2197538 — intervention group
Group type: COMPARATOR
Intervention: Azidothymidine alone
Number of subjects: 27
Study 2197538 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentamidine aerosol
Number of subjects: 27
Study 65196 — intervention group
Group type: EXPERIMENTAL
Intervention: Candicidin (300 mg daily dose, 6 capsules per day)
Number of subjects: 62
Study 65196 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 62
Study 31532589 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenoten (10 drops per day)
Number of subjects: 184
Study 28466585 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin, dutasteride and imidafenacin
Number of subjects: 163
Study 28466585 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin and dutasteride
Number of subjects: 163
Study 25446217 — intervention group
Group type: EXPERIMENTAL
Intervention: High-MUFA meal
Number of subjects: 16
Study 25446217 — intervention group
Group type: EXPERIMENTAL
Intervention: High-SFA meal
Number of subjects: 16
Study 25446217 — intervention group
Group type: EXPERIMENTAL
Intervention: High-PUFA meal
Number of subjects: 16
Study 23828184 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy
Number of subjects: 48
Study 23828184 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined massage-exercise therapy
Number of subjects: 48
Study 23828184 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy
Number of subjects: 48
Study 23828184 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard medical care)
Number of subjects: 48
Study 21216512 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical polyantibiotic ointment application at CVC exit sites (1 time/week)
Number of subjects: 0
Study 21216512 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical polyantibiotic ointment application at CVC exit sites
Number of subjects: 0
Study 18989889 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel at 250 mg/m2
Number of subjects: 15
Study 18989889 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel at 325 mg/m2
Number of subjects: 15
Study 18989889 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel at 425 mg/m2
Number of subjects: 15
Study 18989889 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel at 550 mg/m2
Number of subjects: 15
Study 18989889 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of paclitaxel and ifosfamide
Number of subjects: 15
Study 18989889 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel (MTD)
Number of subjects: 15
Study 16888407 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton beam radiotherapy followed by transpupillary thermotherapy (TTT) at 1, 6, and 12 months
Number of subjects: 151
Study 16888407 — intervention group
Group type: COMPARATOR
Intervention: Proton beam radiotherapy alone (60 Gy in 4 fractions)
Number of subjects: 151
Study 15282382 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma attacks in the last 12 months
Number of subjects: 11168
Study 15282382 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma medication usage
Number of subjects: 11168
Study 15282382 — intervention group
Group type: COMPARATOR
Intervention: Reported symptoms of asthma
Number of subjects: 11168
Study 15282382 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal allergies
Number of subjects: 11168
Study 11347287 — intervention group
Group type: COMPARATOR
Intervention: Chlorella supplementation (10 g in tablet form and 100 mL liquid extract daily for 2 or 3 months)
Number of subjects: 97
Study 11347287 — intervention group
Group type: COMPARATOR
Intervention: Chlorella supplementation
Number of subjects: 97
Study 9272481 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (subanesthetic doses)
Number of subjects: 13
Study 9272481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 8499051 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 0
Study 8499051 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3693583 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting propranolol 160 mg/d
Number of subjects: 51
Study 3693583 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional propranolol 40 mg qid
Number of subjects: 51
Study 3693583 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 31093503 — intervention group
Group type: EXPERIMENTAL
Intervention: Multispecies probiotic supplementation (F1 and F2)
Number of subjects: 0
Study 31093503 — intervention group
Group type: COMPARATOR
Intervention: Placebo (F3)
Number of subjects: 0
Study 28377360 — intervention group
Group type: EXPERIMENTAL
Intervention: Shangbai ointment treatment
Number of subjects: 50
Study 28377360 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study 25308350 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin administration
Number of subjects: 0
Study 24092872 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone (2 mg/kg/d for 3 days)
Number of subjects: 87
Study 24092872 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone (0.6 mg/kg, 1 dose)
Number of subjects: 87
Study 20718826 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative dietary restriction (30% calorie-restricted diet followed by one day of water-only fasting)
Number of subjects: 30
Study 20718826 — intervention group
Group type: COMPARATOR
Intervention: Ad libitum intake (control group)
Number of subjects: 30
Study 20718826 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative dietary restriction
Number of subjects: 30
Study 19683043 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.6% Ageratina pichinchensis extract
Number of subjects: 122
Study 19683043 — intervention group
Group type: EXPERIMENTAL
Intervention: 16.8% Ageratina pichinchensis extract
Number of subjects: 122
Study 17339866 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-acting inhaler beta2 mimetic as required + 800 mug inhaler budesonide + leukotriene receptor antagonist
Number of subjects: 31
Study 17339866 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-acting inhaler beta2 mimetic as required + 800 mug inhaler budesonide
Number of subjects: 31
Study 17339866 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-acting inhaler beta2 mimetic as required + 800 mug inhaler budesonide + vitamin E
Number of subjects: 31
Study 17339866 — intervention group
Group type: COMPARATOR
Intervention: Control group (10 healthy volunteers)
Number of subjects: 31
Study 15076943 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganciclovir implant plus oral ganciclovir
Number of subjects: 42
Study 15076943 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia and inpatient surgery
Number of subjects: 42
Study 15076943 — intervention group
Group type: COMPARATOR
Intervention: Local anesthesia and outpatient surgery
Number of subjects: 42
Study 15076943 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 42
Study 11790415 — intervention group
Group type: EXPERIMENTAL
Intervention: Thicker shake (high viscosity)
Number of subjects: 84
Study 11790415 — intervention group
Group type: COMPARATOR
Intervention: Thinner shake (low viscosity)
Number of subjects: 84
Study 9744203 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group discussions with women in the community
Number of subjects: 41
Study 9744203 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group discussions with breast cancer patients
Number of subjects: 41
Study 9744203 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group discussions with both groups
Number of subjects: 41
Study 7977879 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined nortriptyline and interpersonal psychotherapy
Number of subjects: 32
Study 2658142 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone 400 mg/d
Number of subjects: 24
Study 2658142 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 1103724 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable Frequency Regimen (VFR)
Number of subjects: 20
Study 1103724 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable Dosage Regimen (VDR)
Number of subjects: 20
Study 31996709 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based cognitive training (Lumosity Cognitive Training) for 8 weeks, 5 sessions per week (40 sessions)
Number of subjects: 2
Study 31996709 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group (Waiting-first Group)
Number of subjects: 2
Study 31518044 — intervention group
Group type: EXPERIMENTAL
Intervention: Aged garlic extract (AGE) 2400 mg daily for 1 year
Number of subjects: 122
Study 31518044 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 28526467 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided transversus abdominis plane block (UT group; n=38)
Number of subjects: 75
Study 28526467 — intervention group
Group type: COMPARATOR
Intervention: Surgical transversus abdominis plane block (ST group; n=37)
Number of subjects: 75
Study 25114123 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed appliance with multi-brackets
Number of subjects: 62
Study 25114123 — intervention group
Group type: COMPARATOR
Intervention: Removable appliance with protruding springs
Number of subjects: 62
Study 23051178 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy (1 hour per week for 12 weeks)
Number of subjects: 83
Study 23051178 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut-directed hypnotherapy
Number of subjects: 83
Study 22000914 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone calls from specialized social workers
Number of subjects: 131
Study 22000914 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 131
Study 22436099 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of nifedipine with 480 mg of curcuminoid (6 tablets of turmeric extract)
Number of subjects: 10
Study 22436099 — intervention group
Group type: COMPARATOR
Intervention: 10 mg of nifedipine (control)
Number of subjects: 10
Study 17302248 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotypic resistance testing (Virtual Phenotype)
Number of subjects: 170
Study 17302248 — intervention group
Group type: COMPARATOR
Intervention: No testing
Number of subjects: 170
Study 12937334 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated interactive voice response (IVR) intervention for caregivers, yearlong access.
Number of subjects: 100
Study 12937334 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group.
Number of subjects: 100
Study 10729390 — intervention group
Group type: EXPERIMENTAL
Intervention: LPL gene analysis
Number of subjects: 20
Study 10729390 — intervention group
Group type: EXPERIMENTAL
Intervention: HTGL gene analysis
Number of subjects: 20
Study 10729390 — intervention group
Group type: EXPERIMENTAL
Intervention: Ser267Phe mutation
Number of subjects: 20
Study 9013080 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 beta‐oestradiol and norethisterone acetate (intervention group)
Number of subjects: 28
Study 9013080 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules (control group)
Number of subjects: 28
Study 1521049 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette yield, consumption, self-reported inhalation, and puffing characteristics under standardized smoking conditions (30 puffs through a holder)
Number of subjects: 144
Study 1521049 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette yield, consumption, self-reported inhalation, and puffing characteristics under natural smoking conditions
Number of subjects: 144
Study 1521049 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette yield, consumption, self-reported inhalation, and puffing characteristics
Number of subjects: 144
Study 1521049 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized smoking conditions (30 puffs through a holder)
Number of subjects: 144
Study 1521049 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural smoking conditions
Number of subjects: 144
Study 3156805 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g spectinomycin
Number of subjects: 200
Study 3156805 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg ceftriaxone
Number of subjects: 200
Study 31870458 — intervention group
Group type: EXPERIMENTAL
Intervention: Body acupressure
Number of subjects: 90
Study 31870458 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupressure
Number of subjects: 90
Study 31870458 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 90
Study 30035423 — intervention group
Group type: EXPERIMENTAL
Intervention: Speroton complex with general therapy
Number of subjects: 60
Study 30035423 — intervention group
Group type: COMPARATOR
Intervention: General therapy (Control Group)
Number of subjects: 60
Study 27484782 — intervention group
Group type: EXPERIMENTAL
Intervention: LED-RL phototherapy at doses of 160 J/cm², 320 J/cm², 480 J/cm², and 640 J/cm²
Number of subjects: 50
Study 27484782 — intervention group
Group type: COMPARATOR
Intervention: Mock therapy
Number of subjects: 50
Study 25236915 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilazodone (5 mg) with ketoconazole (200 mg once daily)
Number of subjects: 67
Study 25236915 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilazodone (10 mg) with ketoconazole (200 mg once daily)
Number of subjects: 67
Study 25236915 — intervention group
Group type: EXPERIMENTAL
Intervention: Vilazodone (40 mg once daily) with carbamazepine (steady-state)
Number of subjects: 67
Study 22745661 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial lead with a tip-to-ring spacing of 1.1 mm, programmed with postventricular atrial blanking (PVAB) to 60 ms
Number of subjects: 204
Study 22745661 — intervention group
Group type: COMPARATOR
Intervention: Conventional atrial lead with a tip-to-ring spacing of 10 mm, programmed with individually determined optimized PVAB
Number of subjects: 204
Study 19995884 — intervention group
Group type: EXPERIMENTAL
Intervention: Restriction of time in bed by delaying bedtime 30 minutes nightly for 18 months, together with education in healthy sleep practices (SLEEP)
Number of subjects: 64